Dementia, Alzheimer’s, Parkinson’s… mortality from neurological diseases increases in Spain
We live longer and older. Life expectancy continues to increase in Spain, but this is not always accompanied by quality ...
Tag: Alzheimers
Europe changes its evaluation and gives a restricted permit to lecanemab, the controversial drug against Alzheimer’s
The European Medicines Agency (EMA) has re-evaluated the anti-Alzheimer's drug lecanemab and has decided to authorize the product. The decision ...
Europe reviews its decision and decides to approve lecanemab against Alzheimer’s
Less than four months later, the European Medicines Agency recommends marketing authorization for lecanemab for the treatment of Alzheimer's disease. ...
Europe rectifies and gives the green light to a new drug against Alzheimer’s
The European Medicines Agency (EMA) has approved in Europe a promising drug against Alzheimer's that it had rejected in July. ...
Brussels rectifies and gives the green light to lecanemab, the first treatment for Alzheimer’s in early stages
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued, after months of ...
Alzheimer’s: how to identify the first symptoms and available treatments
Alzheimer's, whose world day is celebrated every September 21, is a type of dementia, a neurodegenerative disease that leads to ...
Luis Aguilar, at risk of developing Huntington’s disease: “There is more hope than a few years ago”
The Huntington's disease is, after Alzheimer's and the Parkinson'sthe third most common neurodegenerative disease. A disease that, being genetic origincan ...
The frequent habit that can accelerate the risk of suffering from Alzheimer’s, according to a study
A new study has linked a common habit among adults to the progression of the disease. Alzheimer's. This condition slowly ...
Alzheimer’s and frontotemporal dementia: Two paths to cognitive loss
The brain is like a map full of routes that guide every aspect of our daily lives. Alzheimer's and frontotemporal ...
The ‘new era’ of Alzheimer’s: biomarkers and drugs to get ahead of the disease
After two decades without news, in the last year the US has approved two drugs that manage to slow the ...